Inhibrx Biosciences, Inc. (INBX) total debt

Total debt · fiscal 2025
$107.01M

Inhibrx Biosciences, Inc. (INBX) carried total debt of $107.01M at the end of fiscal 2025 (December 31, 2025). That is 1229.7% higher than the $8.05M of fiscal 2024. Figures as of 18 Nov 2026, 08:28 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$107.01M
Change on fiscal 2024
+1229.7%
Highest on record
$210.14Mfiscal 2023
Lowest on record
$5.03Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Inhibrx Biosciences, Inc. total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $210.14M in fiscal 2023 and the lowest $5.03M in fiscal 2022.

Total debt was 13.4× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

Inhibrx Biosciences, Inc. total debt, year by year

Inhibrx Biosciences, Inc. (INBX) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$107.01M 1,229.7% up13.4×
2024$8.05M 96.2% down0.1×
2023$210.14M 4,075.3% up4.8×
2022$5.03M——

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on INBX

Inhibrx Biosciences, Inc., figure by figure

Inhibrx Biosciences, Inc. (INBX) overview: price, valuation and scorecard

Inhibrx Biosciences, Inc. total debt: questions and answers

How much debt does Inhibrx Biosciences, Inc. have?

Inhibrx Biosciences, Inc. (INBX) carried total debt of $107.01M at the end of fiscal 2025 (December 31, 2025). That is 1229.7% higher than the $8.05M of fiscal 2024.

What are the highest and lowest total debt figures on record for Inhibrx Biosciences, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was $210.14M in fiscal 2023 and the lowest $5.03M in fiscal 2022.

How does Inhibrx Biosciences, Inc.'s debt compare with its equity?

Total debt was 13.4× shareholders' equity at the end of fiscal 2025.

How is Inhibrx Biosciences, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Inhibrx Biosciences, Inc. (INBX) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/INBX/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.